Vaxil Bio

Vaxil Bio EPS

Earnings per Share (EPS) of Vaxil Bio (VXL.V) as of Oct 18, 2026.

EPS

0.00CAD

YoY

-393.26%

Last updated:

Earnings per Share (EPS) of Vaxil Bio is 2025 0.00 CAD. Earnings per Share (EPS) of Vaxil Bio was 2024 -0.00 CAD. It decreases by -393.26% higher compared to the previous year.

The Vaxil Bio EPS history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EPS
Date
EPS
Jan 1, 2018
-0.01 CAD
Jan 1, 2019
-0.01 CAD
Jan 1, 2020
-0.01 CAD
Jan 1, 2021
-0.01 CAD
Jan 1, 2022
-0.00 CAD
Jan 1, 2023
-0.00 CAD
Jan 1, 2024
-0.00 CAD
Jan 1, 2025
0.00 CAD
The Vaxil Bio EPS history
YEAREPSYoY
0.00CAD-393.26%
-0.00CAD+69,978.23%
-0.00CAD-99.96%
-0.00CAD-40.77%
-0.01CAD-45.44%
-0.01CAD+0.70%
-0.01CAD+10.41%
-0.01CAD-66.72%
-0.04CAD-63.10%
-0.10CAD-32.13%
-0.14CAD+40,017.42%
-0.00CAD-99.60%
-0.09CAD-78.31%
-0.41CAD-39.04%
-0.66CAD-1.45%
-0.67CAD+221.53%
-0.21CAD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Vaxil Bio Stock analysis

What does Vaxil Bio do? Vaxil Bio Ltd is a biotechnology company based in Toronto, Canada, specializing in immunotherapy for cancer and infectious diseases. Listed on March 2, 2011, the firm develops novel treatments using a platform based on signal peptides. Its advanced product, ImMucin, is a vaccine derived from MUC1 signal peptides that completed Phase I/II trials for multiple myeloma. The company also holds candidates for COVID-19 and tuberculosis vaccines, as well as monoclonal antibodies for oncology and infectious diseases. Additionally, Vaxil Bio has initiated a pre-clinical program for a drug delivery polymer targeting E-selectin, licensed from BGN Technologies, aiming to create targeted therapies against critical disease targets. Vaxil Bio is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Vaxil Bio stock

On Eulerpool you can find the complete historical development of Earnings per Share (EPS) Vaxil Bio since 2006 – with annual values, charts, and detailed analysis.

Earnings per Share measures the portion of a company's profit allocated to each outstanding share. It is a key metric for assessing a company's profitability on a per-share basis.

EPS = Net Income / Shares Outstanding

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Vaxil Bio

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Vaxil Bio